Author Question: Section ______________________________ of the Sarbanes-Oxley Act of 2002 requires disclosure to the ... (Read 150 times)

nmorano1

  • Hero Member
  • *****
  • Posts: 598
Section ___________________ ___________ of the Sarbanes-Oxley Act of 2002 requires disclosure to the public on a rapid and current basis of material changes in an organization's financial condition.
 Fill in the blank(s) with correct word

Question 2

A government entered into a general government capital lease for equipment during the year. The capitalizable cost of the equipment was 400,000 . A down payment of 40,000 was made.
 
  The General Fund should report in its statement of revenues, expenditures, and changes in fund balance an
  A. Other financing use of 400,000.
  B. Expenditure of 360,000.
  C. Other financing source of 400,000.
  D. Other financing source of 360,000.



brittiany.barnes

  • Sr. Member
  • ****
  • Posts: 321
Answer to Question 1

409

Answer to Question 2

D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Approximately 70% of expectant mothers report experiencing some symptoms of morning sickness during the first trimester of pregnancy.

Did you know?

Your heart beats over 36 million times a year.

Did you know?

Though methadone is often used to treat dependency on other opioids, the drug itself can be abused. Crushing or snorting methadone can achieve the opiate "rush" desired by addicts. Improper use such as these can lead to a dangerous dependency on methadone. This drug now accounts for nearly one-third of opioid-related deaths.

Did you know?

The first successful kidney transplant was performed in 1954 and occurred in Boston. A kidney from an identical twin was transplanted into his dying brother's body and was not rejected because it did not appear foreign to his body.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library